Predictive Value of Baseline CTQ-SSS Scores for Progression to Carpal Tunnel Release Surgery: A Cohort Study

Last updated: July 3, 2023
Sponsor: Ahram Canadian University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Carpal Tunnel Syndrome

Treatment

CTQ-SSS scores

Clinical Study ID

NCT05838963
012/0023444
  • Ages 18-60
  • All Genders

Study Summary

This study aims to determine the predictive value of baseline CTQ-SSS scores for progression to carpal tunnel release (CTR) surgery in patients with carpal tunnel syndrome (CTS). It will be a prospective cohort study involving at least 200 patients with CTS who are undergoing nonsurgical management. Participants will complete the CTQ-SSS and other functional measures at baseline, 3 months, 6 months, and 12 months, and the primary outcome will be progression to CTR surgery. Logistic regression models will be used to assess the predictive value of baseline CTQ-SSS scores for progression to CTR surgery, adjusting for potential confounding factors such as age, sex, and baseline symptom severity. The results of this study can help clinicians identify patients who may benefit from early surgical intervention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with symptoms consistent with carpal tunnel syndrome, such as numbness,tingling, or pain in the hand or wrist.
  • Patients with a positive nerve conduction study confirming carpal tunnel syndrome, ORpatients with clinical symptoms and signs consistent with carpal tunnel syndrome if anerve conduction study is not available or inconclusive.
  • Patients who have not undergone hand or wrist surgery within the past 6 months.
  • Patients who are 18 years of age or older.
  • Patients who are willing and able to provide informed consent and comply with studyrequirements.

Exclusion

Exclusion Criteria:

  • Patients with a history of hand or wrist surgery within the past 6 months.
  • Patients with severe hand or wrist pain that would prevent completion of the outcomemeasures or interfere with their ability to participate in the study.
  • Patients with severe cognitive impairment or language barrier that would preventunderstanding of the study instructions or interfere with their ability to participatein the study.
  • Patients with other neurologic or musculoskeletal disorders that could affect handfunction or interfere with test completion.
  • Pregnant or breastfeeding women.
  • Patients who have participated in another clinical trial within the past 30 days.

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: CTQ-SSS scores
Phase:
Study Start date:
July 12, 2023
Estimated Completion Date:
November 01, 2024

Connect with a study center

  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University

    Al Ḩayy Ath Thāmin, Giza 3221405
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.